4Filed Aug 25, 8:00 PM ET

Bankwell Financial (BWFG) Director Lawrence Seidman Buys 2,540 Shares

$BWFG · Bankwell Financial Group, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Bankwell Financial (BWFG) Director Lawrence Seidman Buys 2,540 Shares

What Happened
Lawrence B. Seidman, a director of Bankwell Financial Group, acquired a total of 2,540 shares in multiple open-market purchases on August 25, 2026. The six trades ranged from $65.89 to $66.01 per share for a combined cash outlay of approximately $167,425 (average price ≈ $65.92). Purchases (transaction code P) are buys rather than sales and are typically viewed as more informative about insider sentiment than routine disposals.

Key Details

  • Transaction date: August 25, 2026 (reported on Form 4 filed August 26, 2026).
  • Individual lots:
    • 994 shares @ $65.89 = $65,495
    • 259 shares @ $65.94 = $17,078
    • 219 shares @ $65.96 = $14,445
    • 662 shares @ $65.90 = $43,626
    • 262 shares @ $65.94 = $17,276
    • 144 shares @ $66.01 = $9,505
  • Total: 2,540 shares for ~$167,425 (avg ≈ $65.92/share).
  • Shares owned after the transaction: not specified in the provided filing details.
  • Footnotes in the filing note prior restricted stock grants with vesting schedules (see Context).
  • Filing timing: transaction occurred 2026-08-25 and the Form 4 was filed 2026-08-26 (filed next day).

Context

  • The filing includes four footnotes describing previously granted restricted stock awards:
    • F1: 1,455 RSUs granted 2/9/2026 — vesting in three equal installments of 485 on 2/7/2027, 2/7/2028 and 2/7/2029 (none vested yet).
    • F2: 1,800 RSUs granted 2/7/2025 — 600 vested (as of filing), 600 to vest 2/7/2027, 600 to vest 2/7/2028.
    • F3: 1,600 RSUs granted 12/29/2023 — 1,066 vested as of filing (533 vested 2/7/2025; remaining vest 2/7/2026 and 2/7/2027).
    • F4: 1,600 RSUs granted 12/30/2022 — vesting in four annual installments; 1,200 vested as of filing.
  • These restricted stock items are awards subject to vesting and are separate from the open-market purchases reported here.
  • No 10b5-1 trading plan, tax-withholding sale, or exercise-of-option language was indicated in the provided transaction details.